Connect with us

Hi, what are you looking for?

Thursday, Feb 22, 2024
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.

The weed wire

Canopy Rivers invests $2M into Edmonton edibles company

Investment deal comes days after parent company Canopy Growth got a $245 million injection from its largest shareholder

Canopy Rivers invests $2M into Edmonton edibles company
Canopy Rivers invests $2M into Edmonton edibles company

Canopy Rivers Inc. (TSX-V: RIV) is making a sizable bet that Canada’s appetite for cannabis-infused edibles isn’t being satisfied.

On Monday, the venture capital arm of Canopy Growth (TSX: WEED) said it invested $2 million in Dynaleo Inc., an Edmonton-based company focused on edible weed gummies.

Dynaleo has built a manufacturing facility and said it’s submitted an application to Health Canada for a licence to process up to 400 million individual gummies annually.

Canopy Rivers said the private weed firm is developing a pipeline of white-label edible manufacturing deals to service Canada’s “underserved and underdeveloped segment of the cannabis market.”

Canopy Rivers CEO Narbé Alexandrian predicts Dynaleo will become a market leader in manufacturing edibles.

“We think Dynaleo’s manufacturing capabilities, combined with its capable management team, position it to help close this supply gap in the short term and become a trusted manufacturer of cannabis edibles in the long term,” he said in a statement.

Canopy Rivers noted how strict regulations in Canada means less companies have invested in building the infrastructure to produce gummies.

Meanwhile, major extractor MediPharm Labs (TSX: LABS) said late March that the industry has been slow to get finished extract-based products on the market since becoming legal on Oct. 17, 2019.

Read more: MediPharm blames slow cannabis 2.0 rollout for Q4 revenue drop

Cannabis edibles market still untapped

Canopy Rivers says the limited number of edibles on the market in Canada today are consistently selling out relative to other products.

The weed venture firm points to Headset data that gummies make up around 55 per cent of edible demand in mature cannabis markets in Colorado and California.

Market researchers at Deloitte projected last year that Canada’s edibles market would eventually fetch $1.6 billion, making it the biggest segment among 2.0 products.

“On top of helping Canada’s licensed producers close the supply gap, we also believe that Dynaleo will play a role in expanding the total addressable market for cannabis products, with market research indicating that new consumers are more likely to enter the cannabis market through edibles than other products,” Alexandrian added.

Canopy Rivers says the investment deal with Dynaleo is structured as an unsecured convertible debenture with additional warrant coverage. Upon conversion of the debenture and exercise of the warrants, Canopy Rivers’s ownership stake in the company will be 12.2 per cent.

Canopy Rivers has invested in a wide range of cannabis companies, from TerrAscend (CSE: TER) to Seattle-based data firm Headset.

The company says that as its portfolio continues to develop, enterprises will be provided with opportunities to work with Canopy Growth Corporation.

On Friday, Corona beer maker Constellation Brands Inc. exercised warrants to buy shares of Canopy Growth, increasing Constellation’s stake to 38.6 per cent.

Canopy CEO David Klein said the $245 million injection from Constellation strengthens its ability to pursue market opportunities in Canada, the U.S. and other key global markets.

Top image via Deposit Photos


Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like


The Indian research company says the market will be expanding at a 20.4 per cent CAGR during the next 9 years


The survey results follow the city of Berkeley decriminalizing psychedelic plants and fungi on Tuesday


'We have a big team behind us and we have a lot of people supporting us' said the store's co-owner on Thursday


The development could mark a significant stride in the field of drug testing and law enforcement